NO934834L - 2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse - Google Patents

2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse

Info

Publication number
NO934834L
NO934834L NO934834A NO934834A NO934834L NO 934834 L NO934834 L NO 934834L NO 934834 A NO934834 A NO 934834A NO 934834 A NO934834 A NO 934834A NO 934834 L NO934834 L NO 934834L
Authority
NO
Norway
Prior art keywords
compound
gly
amino
glu
tht
Prior art date
Application number
NO934834A
Other languages
English (en)
Norwegian (no)
Other versions
NO934834D0 (no
Inventor
Seiichi Tanida
Tsuneaki Hida
Mitsuhiro Wakimasu
Setsuo Harada
Koichi Yukishige
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO934834D0 publication Critical patent/NO934834D0/no
Publication of NO934834L publication Critical patent/NO934834L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO934834A 1992-12-28 1993-12-27 2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse NO934834L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34906292 1992-12-28
JP5618593 1993-03-16
JP18173593 1993-07-22

Publications (2)

Publication Number Publication Date
NO934834D0 NO934834D0 (no) 1993-12-27
NO934834L true NO934834L (no) 1994-06-29

Family

ID=27295829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934834A NO934834L (no) 1992-12-28 1993-12-27 2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse

Country Status (15)

Country Link
US (1) US5478808A (fr)
EP (1) EP0604957B1 (fr)
KR (1) KR940014436A (fr)
CN (1) CN1094731A (fr)
AT (1) ATE170871T1 (fr)
AU (1) AU666789B2 (fr)
CA (1) CA2112523A1 (fr)
DE (1) DE69320931T2 (fr)
FI (1) FI935888A (fr)
HU (1) HUT65865A (fr)
IL (1) IL108173A (fr)
NO (1) NO934834L (fr)
NZ (1) NZ250588A (fr)
PH (1) PH30687A (fr)
TW (1) TW264479B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030046389A (ko) * 2000-09-01 2003-06-12 그리폰 테라퓨틱스, 인코포레이티드 친핵체에 안정한 티오에스테르 발생 화합물, 제조 및 사용방법
EP1382352A1 (fr) * 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Conjugués de bisacylpropylcystéine et leur utilisation
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
AU2006259630B2 (en) * 2005-06-13 2011-10-27 Cleveland Biolabs, Inc. Methods of protecting against apoptosis using lipopeptides
WO2007099650A1 (fr) * 2006-03-01 2007-09-07 Fukuoka Prefectural Government Vecteur contenant un lipide peptidique et procede permettant d'introduire un compose dans des cellules l'utilisant
DE102009034779A1 (de) * 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
KR101853513B1 (ko) * 2010-03-23 2018-04-30 노파르티스 아게 감염, 염증, 호흡기 질환 등의 치료를 위해 사용되는 ｔｌｒ2 효능제로서의 화합물 (시스테인 기재 리포펩티드) 및 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860893D1 (en) * 1977-06-20 1981-11-05 Ciba Geigy Ag Lipopeptides, process for their preparation and pharmaceutical compositions containing them
EP0014815A3 (fr) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
EP0114787B1 (fr) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Dérivés peptidiques
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
JPH0446194A (ja) * 1990-06-13 1992-02-17 Fujisawa Pharmaceut Co Ltd Ｗｓ１２７９ａ物質、その生産法及び用途
JPH0499796A (ja) * 1990-08-13 1992-03-31 Kazuo Achinami 新規リポペプタイド及び抗腫瘍剤
DK0548024T3 (da) * 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling

Also Published As

Publication number Publication date
HU9303761D0 (en) 1994-04-28
TW264479B (fr) 1995-12-01
AU5261493A (en) 1994-07-07
DE69320931T2 (de) 1999-05-20
CA2112523A1 (fr) 1994-06-29
US5478808A (en) 1995-12-26
KR940014436A (ko) 1994-07-18
ATE170871T1 (de) 1998-09-15
NO934834D0 (no) 1993-12-27
FI935888A (fi) 1994-06-29
EP0604957A1 (fr) 1994-07-06
CN1094731A (zh) 1994-11-09
NZ250588A (en) 1995-03-28
DE69320931D1 (de) 1998-10-15
IL108173A (en) 1998-03-10
HUT65865A (en) 1994-07-28
IL108173A0 (en) 1994-04-12
FI935888A0 (fi) 1993-12-27
EP0604957B1 (fr) 1998-09-09
PH30687A (en) 1997-09-16
AU666789B2 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
EP0114787A2 (fr) Dérivés peptidiques
EP0111266A2 (fr) Tétrapeptides substitués
JPS6360760B2 (fr)
DK2697246T3 (en) SELECTIVE CYSTEIN PROTEASE INHIBITORS AND USES THEREOF
JPH04208299A (ja) プロリルエンドペプチターゼ阻害ペプチド
NO934834L (no) 2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse
US8835392B2 (en) Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors
US5478809A (en) TAN-1511, its derivatives, production and use thereof
EP0931792B1 (fr) Depsipeptides comportant des acides aminés non naturelles
JP3556967B2 (ja) ２−アミノ−６，７−ジヒドロキシ−４−チアヘプタン酸誘導体
CA2131639A1 (fr) Derives du thioglycerol
EP0638588A1 (fr) Dérivés de l'acide 2-amino-6,7-dihydroxy-4-thiaheptanoique, leur préparation et utilisation
Blagodarov et al. Improving the synthesis of hemin derivatives and their effect on bacterial biofilms
JP2934905B2 (ja) 新規リポペプタイド及び抗腫瘍剤
JPH07252295A (ja) ６，７−ジヒドロキシ−４−チアヘプタン酸誘導体
JPH0499796A (ja) 新規リポペプタイド及び抗腫瘍剤
FR2543546A1 (fr) Derives de gonadoreline contenant un groupe b-aspartyle, procede pour leur preparation et preparations pharmaceutiques les contenant
EP0454302A2 (fr) Dérivés de tuftsin
JPH07126243A (ja) チオグリセロール誘導体
JPH07145084A (ja) Ｔａｎ−１５１１関連化合物
JPH07252163A (ja) 血小板減少症治療剤
WO2021129579A1 (fr) Dérivé de hème et son procédé de préparation et son utilisation
JPH0253800A (ja) ペプチド及び抗痴呆剤
JPH11322786A (ja) 非天然アミノ酸を含有するデプシペプチド
Samir et al. SYNTHESIS AND BIOLOGICAL EVALUATION OF CYCLO (NITRO) PROCTOLIN ANALOGS